237 related articles for article (PubMed ID: 38129903)
1. Differences in buprenorphine prescribing readiness among primary care professionals with and without X-waiver training in the US.
Franz B; Dhanani LY; Hall OT; Brook DL; Simon JE; Miller WC
Harm Reduct J; 2023 Dec; 20(1):180. PubMed ID: 38129903
[TBL] [Abstract][Full Text] [Related]
2. Survey of Barriers and Facilitators to Prescribing Buprenorphine and Clinician Perceptions on the Drug Addiction Treatment Act of 2000 Waiver.
Lanham HJ; Papac J; Olmos DI; Heydemann EL; Simonetti N; Schmidt S; Potter JS
JAMA Netw Open; 2022 May; 5(5):e2212419. PubMed ID: 35552721
[TBL] [Abstract][Full Text] [Related]
3. Buprenorphine Waiver Attitudes Among Primary Care Providers.
Lai B; Croghan I; Ebbert JO
J Prim Care Community Health; 2022; 13():21501319221112272. PubMed ID: 35822763
[TBL] [Abstract][Full Text] [Related]
4. Barriers and facilitators to nurse practitioner buprenorphine prescribing for opioid use disorder in primary care settings.
Speight C; Caiola C; Tyndall DE; Scott ES
J Am Assoc Nurse Pract; 2023 Feb; 35(2):112-121. PubMed ID: 36512806
[TBL] [Abstract][Full Text] [Related]
5. Prescribing Practices of Nurse Practitioners and Physician Assistants Waivered to Prescribe Buprenorphine and the Barriers They Experience Prescribing Buprenorphine.
Andrilla CHA; Jones KC; Patterson DG
J Rural Health; 2020 Mar; 36(2):187-195. PubMed ID: 31650634
[TBL] [Abstract][Full Text] [Related]
6. A survey of barriers and facilitators to the adoption of buprenorphine prescribing after implementation of a New Jersey-wide incentivized DATA-2000 waiver training program.
Nyaku AN; Zerbo EA; Chen C; Milano N; Johnston B; Chadwick R; Marcello S; Baston K; Haroz R; Crystal S
BMC Health Serv Res; 2024 Feb; 24(1):179. PubMed ID: 38331802
[TBL] [Abstract][Full Text] [Related]
7. Association of a Multimodal Educational Intervention for Primary Care Physicians With Prescriptions of Buprenorphine for Opioid Use Disorders.
Clark B; Kai M; Dix R; White J; Rozenfeld Y; Levy S; Engstrom K
JAMA Netw Open; 2019 Oct; 2(10):e1913818. PubMed ID: 31642929
[TBL] [Abstract][Full Text] [Related]
8. Buprenorphine misinformation and willingness to treat patients with opioid use disorder among primary care-aligned health care professionals.
Franz B; Dhanani LY; Hall OT; Brook DL; Fenstemaker C; Simon JE; Miller WC
Addict Sci Clin Pract; 2024 Jan; 19(1):7. PubMed ID: 38243307
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.
Jones CM; McCance-Katz EF
Addiction; 2019 Mar; 114(3):471-482. PubMed ID: 30194876
[TBL] [Abstract][Full Text] [Related]
10. Overcoming Barriers to Prescribing Buprenorphine for the Treatment of Opioid Use Disorder: Recommendations from Rural Physicians.
Andrilla CHA; Moore TE; Patterson DG
J Rural Health; 2019 Jan; 35(1):113-121. PubMed ID: 30339720
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Resident Physicians' Knowledge of and Attitudes Towards Prescribing Buprenorphine for Patients With Opioid Use Disorder.
Shuey B; Lee D; Ugalde I; Borgan S; Bresnan C; Qureshi M; Mhaskar R; Oxner A
J Addict Med; 2021 May-Jun 01; 15(3):219-225. PubMed ID: 33079729
[TBL] [Abstract][Full Text] [Related]
12. Impact of Policy Change on Access to Medication for Opioid Use Disorder in Primary Care.
Krupp J; Hung F; LaChapelle T; Yarrington ME; Link K; Choi Y; Chen H; Marais AD; Sachdeva N; Chakraborty H; McKellar MS
South Med J; 2023 Apr; 116(4):333-340. PubMed ID: 37011580
[TBL] [Abstract][Full Text] [Related]
13. Barriers to Buprenorphine Prescribing for Opioid Use Disorder in Hospice and Palliative Care.
Janet Ho J; Jones KF; Sager Z; Neale K; Childers JW; Loggers E; Merlin JS
J Pain Symptom Manage; 2022 Aug; 64(2):119-127. PubMed ID: 35561938
[TBL] [Abstract][Full Text] [Related]
14. Adapting and scaling a single site DEA X-waiver training program to a statewide initiative: Implementing GetWaiveredTX.
Potter JS; Finley EP; King VL; Lanham HJ; Schmidt S; Schneegans S; Rosen KD
J Subst Abuse Treat; 2022 Jun; 137():108688. PubMed ID: 35058105
[TBL] [Abstract][Full Text] [Related]
15. Positive contact and empathy as predictors of primary care providers' willingness to prescribe medications for opioid use disorder.
Dhanani LY; Miller WC; Hall OT; Brook DL; Simon JE; Go V; Franz B
SSM Ment Health; 2023 Dec; 4():. PubMed ID: 38558957
[TBL] [Abstract][Full Text] [Related]
16. Primary care professionals' perspectives on tailoring buprenorphine training for rural practice.
Fenstemaker C; Abrams EA; Obringer B; King K; Dhanani LY; Franz B
J Rural Health; 2024 Mar; ():. PubMed ID: 38486066
[TBL] [Abstract][Full Text] [Related]
17. Primary care physicians' preparedness to treat opioid use disorder in the United States: A cross-sectional survey.
Foti K; Heyward J; Tajanlangit M; Meek K; Jones C; Kolodny A; Alexander GC
Drug Alcohol Depend; 2021 Aug; 225():108811. PubMed ID: 34175786
[TBL] [Abstract][Full Text] [Related]
18. Association of Project ECHO Training With Buprenorphine Prescribing by Primary Care Clinicians in Minnesota for Treating Opioid Use Disorder.
Solmeyer AR; Berger AT; Barton SL; Nguyen B; Bart GB; Grahan B; Bell HJ; DeVine KM; Merrick W
JAMA Health Forum; 2022 Nov; 3(11):e224149. PubMed ID: 36399352
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Completing X-Waiver Training and Clinical Addiction Exposure on Internal Medicine Residents Treating Patients With Opioid Use Disorder.
Callister C; Porter S; Vatterott P; Keniston A; McBeth L; Mann S; Calcaterra SL; Limes J
Subst Use Addctn J; 2024 Jul; 45(3):356-366. PubMed ID: 38258815
[TBL] [Abstract][Full Text] [Related]
20. Differences in perceived clinical knowledge uptake among health profession students and licensed clinicians receiving buprenorphine waiver training in Oregon.
Robbins JL; Bonuck K; Thuillier P; Buist C; Carney PA
Subst Abus; 2022; 43(1):825-833. PubMed ID: 35130133
[No Abstract] [Full Text] [Related]
[Next] [New Search]
